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INDUSTRIES PERSPECTIVES ON HEALTHCARE:
DELIVERY IN AN UNCERTAIN POLICY FUTURE
PANELISTS:
DICK COWART, BAKER DONELSON
DARIN GORDON, GORDON & ASSOCIATES, LLC
MICHAEL REGIER, VANDERBILT UNIVERSITY MEDICAL CENTER
Moderated by Professor Debbie Farringer, Belmont University
College of Law
JANUARY 27, 2017
Professor Farringer: Thanks to everyone for coming. Thanks to
Aubrey Beckham and Taylor Wilkins and Grace Ann for putting all
of this together and for all their hard work. And for the whole team
that came together pretty quickly. Actually, you know we just
formed the journal and had all the student involvement at the very
beginning of this first semester of the year. So to throw all this
together and pull it all out has been amazing, so thanks so much to
the students.
I am really excited to be able to introduce our panelists here
for Industry Perspectives. And, its been really funny in trying to craft
questions to think through what to ask these folks. It seems like it
changes day to day with everything that is happening because it is
such a moving target right now, in terms of where things are going
and what we can expect. So a lot of what we are going to talk about
today probably is just “what are some of the various things that have
been thrown out there that might be changing the landscape of
healthcare and what can practitioners think about?” “What do we
need to consider?” And hopefully can just have some good
conversation about various policy proposals and pieces and parts of
health care reform.
So I am going to introduce our panelists. First, to my right
here, is Michael Regier. He is general counsel and secretary for
Vanderbilt University Medical Center in Nashville, Tennessee. He
received his bachelor’s degree in business administration with
highest distinction from the University of Kansas and his Juris
Doctorate from the University of Virginia School of Law, where he
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was a Dillard Fellow. He became General Counsel and Secretary of
VMC on April 30th, 2016. He is responsible for all legal and
regulatory matters as well as risk management and insurance, as
well as the compliance program, which I am sure is a huge, huge
job, so he has been busy. Before joining VUMC he had served since
August 2012 as Vice President and Chief Legal Officer of Atlantic
Health Systems in Morristown, New Jersey. Which I believe is a
four-hospital – five hospital health system in New Jersey. And
before there he served since June of 2007 as Senior Vice President
of Legal Affairs and General Counsel and Secretary of VHA, now
Visiant, in Irving, Texas. While at VHA he had responsibilities in
legal, risk management, office services, public relations, and
corporate communications teams, as well as the company’s office of
public policy in Washington, DC. Prior to VHA, Mr. Regier served
since September 1995 as Senior Vice President, General Counsel,
Secretary, and Corporate Responsibility Officer for the Seton
Healthcare Network, now Seton Healthcare Family in Austin,
Texas, where he was responsible for legal and corporate governance
matters as well as the compliance program. He also has been in
practice in Chicago, Illinois, prior to that since 1985.
To his right is Mr. Dick Cowart. Mr. Cowart is a recognized
authority in advising senior management regarding policy,
regulatory, and business issues relating to healthcare. He serves as
strategic counsel to healthcare companies, both for-profit and nonprofit, and counsels providers on business, policy, and governance
issues, with an emphasis on business transactions. You might have
seen him – he is nationally known speaker and writer on healthcare
issues and is the national columnist for Medical News Inc. for 18
years and is our own local health business columnist for the
Tennessean for more than 10 years. Mr. Cowart graduated Magna
Cum Laude from the University of Southern Mississippi with his
BSBA and with Honors from the University of Mississippi School
of Law.
And our final panelist, to the far right, is Mr. Darin Gordon.
He is the former Director of Tennessee’s Medicaid program,
TennCare, with 20 years of experience in public health finance,
policy, and operations. He has served both Democratic and
Republican governors and had been in healthcare policy and
innovation nationally, through consultations with over 35 states. Mr.
Gordon is a fellow of the Medical Leadership Institute, and a
member of the Inaugural class of the Nashville Healthcare Council
fellows program, and board member of Leadership Healthcare. Mr.
Gordon is a member of the Cressey & Company Distinguished
Executives Council and a Director of Addus Homecare, Unified
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Care Group, and Siloam Health. He also serves as Chairman of 180
Health Partners and is an advisor for myNexus. He is President and
CEO of Gordon and Associates, LLC.
So, thank you for coming.
As we get started, one of the things that I wanted to talk
about first is, it seems relatively certain that at least some parts, or
potentially all (it’s not totally clear at this point), but some parts of
the ACA1 will be repealed. And there are various proposals for
different replacement plans that have been discussed. And one of
those proposals is the idea of changing Medicaid from its current
structure into a “block grant” program. So can you describe—Mr.
Gordon, I don’t know if you are the best one to take this one given
your history—but tell the audience a bit about what “block grant”
programs are, what that would mean for the TennCare program and
other Medicaid programs, and just some general information about
“block grant” programs and how Tennessee would potentially
prioritize needy populations under that.
Mr. Gordon: Sure. First, thanks for having me, I really appreciate
it. Obviously, everywhere I go, the topic comes up pretty regularly.
But, before I describe block grants, it might be helpful to orient
people to kind of the current state of financing in Medicaid. Think
about it in two parts: there are two investors in Medicaid—the state
and the federal government. The primary investor is the federal
government; they really put more into the equation. In essence, it is
an open-entitlement program from the federal perspective. If a
person is eligible for the program, or they need services that are
covered under Medicaid, the federal government will put forth the
funds needed to reimburse the state for their share of the cost of
those services. However, on the state side, while they still have
bought into this open entitlement concept, they are limited by the
amount of state appropriation that they can contribute to this
equation. So, it’s not as if money can keep going to Medicaid no
matter what as I think some of the articles out there imply today. It
comes that way from the federal government, free flowing and no
cap, but it still requires states to come up with their share of the
funding. I remember talking to different finance commissioners over
the years, and when they come in and try to figure out Medicaid and
seeing that’s the largest budget item, they would ask me “so how
much total money can we get?” And I would respond, “as much state
dollars as we can come up with to match it.” But they would always
respond, “there has got to be a limit,” but there is no limit. And they
1

42. U.S.C. § 18001 et seq. (West 2017).
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are baffled by this. I mean, literally, they would have to ask me this
question over and over to get past it. But accepting federal dollars is
always a challenge for states; and it creates a bit of friction because
the states are constantly needing to make changes to these very large
programs due to state dollar limitations, but the federal government
limits states’ flexibility to change these programs to live within the
available state funds.
Okay, so, think about the block grant concept now. If there
is a “one size fits all” on block grants is being contemplated, this
will cause folks to be scared and worried—I tell people “I’m not
scared of the concept of a block grant.” I am, however, concerned
over the details of a block grant. The idea being that, instead of the
feds saying “regardless of how many people you have, or how many
services are needed, I’m going to send you a set amount of money,
the concept would be that “I’m going to send you some fixed amount
of money from which to work with.” Now, is that less than what you
got the year before? Is it what you go the year before but trended at
a slower trend rate? All those things matter. States can work within
this, if designed well. I can tell you, I can design a block grant
scenario that is something that I would be quite comfortable with.
But, we don’t know if that’s ultimately going to be the case.
Depending on how this comes through Congress, it could be more
of a “function with 90% less money than you had the year before”
approach. Then, that begs the question, “what types of changes am
I allowed to make in order to live within that?” So, funding and
flexibility are hand in hand in this equation. You can’t answer only
half of the equation. Like “we are going to give you this flexibility”
– “Well that’s great, so tell me what the financing is going to look
like.” And vice-versa. They are inextricably linked. The debate is on
what it’s going to look like. We will see. Is it a dramatic change?
Yes. That is probably why you’re hearing about this as regularly as
you are. Because it’s fundamental to the program and how it has
been run for the last 50 years. It is worth pointing out that, block
grants are not new. The concept of block grants in Medicaid actually
was voted on in the Senate and the House under Clinton and
ultimately passed in both houses under Clinton but ultimately was
not signed into law by the President. So it is not a new concept. But,
I think that people feel, more than any other time in our history, that
we are likely to see some significant change in the financing of
Medicaid. In order to, one, constrain the growth, and two, give more
flexibility to the states to manage available funds.
Mr. Cowart: If I might add just two quick points. First, the CMS
administrator, Seema Verma, is not yet confirmed, and she is a good
friend of Darin Gordon and Vice President Pence. In Indiana, they
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had operated under a very broad waiver, so the idea that there would
be a lot more flexibility is safe to say. Secondly, you may recall that
the Sebelius2 decision was really the first United States Supreme
Court decision on the Affordable Care Act3. They stated that the
federal government couldn’t cram down the Medicaid expansion on
the states. So I think that while there will be more flexibility, I think
there will not be a cram down—I think the states will be given
options. And depending on if your trend rate is up or your trend rate
is down, and what your benefit package is, states will be able to
design their flexibility.
Professor Farringer: That leads me to one question – or actually,
go ahead.
Mr. Regier: Well, I was only going to say the only other caveat, is
that’s probably the first thing that the Republican majority will go
after. And we can say to keep your eye on at a very high level, two
things: the flexibility afforded to Executive Director and Chief
Medical Officer of the State Medicaid plans; and then “where is the
baseline set?” I think states, like Tennessee, that have been very,
very efficient in managing their Medicaid plans (some might say
stingy) and have had a 1.5% annual growth could be disadvantaged
versus states like the state of New York, who have been
experiencing 12 to 14% of year over year of growth, and also how
that’s will impact states with an 1115 waiver. That of course
includes Tennessee, which was the first state in the nation to go to a
fully managed care plan approach starting in 1994.
Professor Farringer: That leads nicely into my segue – do you
think that states will be provided funding under block grants based
on existing population or based on the amount of money they have
been given in the past; so, are states that did not expand going to be
negatively affected by the lack expansion?
Mr. Gordon: I would tell you, amongst the states, and some folks
at the federal level, there are people who are trying to sort through
this. The questions that they raise are “Are we at a disadvantage for
not having expanded?” Similar to what was just said, the concept’s
specifics are not “out there.” It’s not a concept that makes me run
and hide. But all those details have to be thought through. And there
seems to be a push to hurry up and get something out there. I would
say, since everyone has agreed that there is going to be a
replacement at the same time a repeal is imposed—we aren’t going
to have an immediate crisis here. I would just encourage everyone
2
3

Nat’l Fed’n of Indep. Bus. v. Sebelius, 567 U.S. 519 (2012).
See generally 42. U.S.C. § 18001 et seq.
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working on this to be thoughtful, if there is ever a time to take
something slow, 18% of GDP is something that we should REALLY
take our time on to get it right. Make sure that you go through all
these different levels of questions and make sure that you don’t set
up a system with perverse incentives.
Professor Farringer: Okay, so, that leads me to another question,
sort of about the idea of repeal and replace. Most of what we talk
about—most of what we hear about—is the pieces that need to be
repealed. We don’t hear a lot about the quality improvement and the
quality-centered programs and a lot of the pilot programs that were
enacted in connection with the ACA.4 So, what do you think is going
to happen to some of those sorts of programs5 and pilot programs
and reimbursement explorations that have been going on as part of
the ACA, that really have nothing to do with insurance, nothing to
do with the individual mandate, and not, I would say, the kind of
hot-button issues that are causing the repeal discussion?
Mr. Regier: You are talking about, I think, the perfect storm
scenario for hospitals. One thing that I would point out is the qualitybased programs that are built into the ACA6 really didn’t start–these
didn’t originate with President Obama. President Bush and former
Health & Human Services Secretary Leavitt, had actually started the
pay-for-performance quality-based system well before President
Obama was elected into office. So these were Republican ideas that
were wrapped into the ACA to appeal to those on the “R” side of the
aisle, to try gain some political support for that statute. You know,
as part of the “three-legged stool” of insurance reforms: increasing
access to coverage, and improving quality while lowering costs—
the three broad components of the ACA. I don’t expect the quality
initiatives to go away—they generally are saving money for the
federal government. Which is—when the policy perspective is “we
aren’t getting what we are paying for in healthcare” –which IS the
policy perspective on the federal level, I don’t expect this will go
away. A risk for providers, though, is that as pay-for-performance is
forcing down Medicare reimbursement (which for a typical hospital
provider is 40% to 45%, even so much as 50%), some institutions,
at the same time, will lose the Medicaid expansion, which means we
4

42 U.S.C. § 1395b-1 (West 2017); see e.g., Ctrs. for Medicare & Medicaid Servs.,
Linking Quality to Payment, available
athttps://www.medicare.gov/hospitalcompare/linking-quality-to-payment.html (last
visited Nov. 1, 2017).
5
See e.g., Melinda K. Abrams et al., The Affordable Care Act’s Payment and Delivery
System Reforms: A Progress Report at Five Years, THE COMMONWEALTH FUND (May 7,
2015) http://www.commonwealthfund.org/publications/issue-briefs/2015/may/acapayment-and-delivery-system-reforms-at-5-years.
6
42 U.S.C. § 1395b-1; 42 U.S.C. §§ 299b –31, 300kk, & 3299b.
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will not have people getting Medicaid coverage; we will lose the
mandate, and we are definitely going to lose the tax credits and tax
subsidies provided under the ACA7, which will affect individuals’
ability to buy insurance coverage. So I think there may be something
to replace that, but it is likely that there will be fewer people with
insurance—so more uncompensated care. And, we still have the
reductions in disproportionate share funding because that was part
of the bargain about expanding coverage. We will reduce the—there
is a payment stream called the disproportionate share hospital
funding which is made available by the federal government to those
providers that provide a very high degree of care to the Medicaid
population—which is, I think, admittedly outside the beltway to be
reimbursed. That, I don’t think, will come back, because the fiscal
pressure is too great, and so you are going to have continued
pressure on providers by way of lower reimbursement, higher
quality expectations, fewer people with insurance, and fewer dollars
coming from the federal government to help offset that cost. It’s a
dream world.
Mr. Cowart: First off, Repeal and Replace—I think we will talk
about that separately. On quality, I think the two big pieces of
bipartisan legislation were MACRA8 and Healthy Cures9, both of
which passed the House and Senate with supermajorities. So, I think
those are pretty solid. However, we have an HHS Secretary who is
a general orthopedic surgeon.10 If you were to ask him if we should
design quality regulations in Washington, he would tell you that’s
nice but physicians decide quality not Washington bureaucrats.
Regarding competition, if we are ever going to have true price
competition we’ve got to have common prices, and we’ve got to
have some degree of transparency. What people are buying and what
does it cost. The process works best when the government can set
some parameters. Frame the marketplace, and then withdraw and
allow the marketplace to do its thing. I think there is a lot of interest
in creating a marketplace, creating transparency, getting pricing and
quality data into the marketplace but not trying to regulate it from
Washington. And I think you are going to see some interesting
things that we have in Tennessee. Now, I think, one of the more
interesting things is what the state put in its state employee health
plan request for proposal. It included a section on bundled payments
to cover all the state employee healthcare insurance. Whoever won
7

42 U.S.C. § 18082. Ctrs. for Medicare and Medicaid Servs., Premium Tax Credit,
HEALTHCARE.GOV, https://www.healthcare.gov/glossary/premium-tax-credit/ (last visited
Nov. 1, 2017).
8
Medicare Access and CHIP Reauthorization Act of 2015, Pub. L. No. 114–10, 129 Stat.
87 (2015).
9
21st Century Cures Act, Pub. L. No. 114-255, 130 Stat. 1033 (2016).
10
Secretary of Health and Human Services at the time of publication was Tom Price.

8

BELMONT PRACS. GUIDE TO HEALTH L. & POL’Y

VOL. 1

that contract had to create pricing for 75 of these highest use
procedures—essentially creating a pricing framework that could be
used as marketplace price and transparency. The State was
attempting to use its purchasing power to create a marketplace but
not necessarily regulate that marketplace.
Mr. Gordon: Dr. Price, the future secretary of HHS, said a lot of
things early on11 that caused me to be concerned for the future of the
Center of Medicare and Medicaid Innovation12 but also about value
based purchasing in general. Even before being considered for the
Secretary of HHS, while he was with the Georgia Medical
Association, he made comments regarding concerns over the move
to value based purchasing.13 However, at his confirmation hearing a
few days ago, he actually said he could see how the Center could be
repurposed and used to promote innovations at the state level and
how the move to value is the new direction things are moving
towards. He said “I could see some value with continuing CMMI
with a different focus” but he didn’t really go into a lot of detail. To
some degree it made me feel “will the priorities be the same?”
Probably not. May there be some different things they invest in?
Probably. Dick is right, the degree of control of those programs
might be lessened and allow things to flow more naturally from the
states. But the idea of value first is one of the biggest components
of all that. With Tennessee being a leader of the country on the move
from volume to value, this is important. If you look at Arkansas or
Ohio, you see other states stepping out as well and doing similar
things to Tennessee and trying to move things forward. Medicare
has been sampling a lot of value based models, but the states have
been sampling a lot of value based models as well. So the move to
value isn't just being driven from within the beltway. So, even if they
change some direction at the federal level on this topic, states will
continue to push forward. In fact, I said whenever we applied for a
grant to help implement value based purchasing that, I wish we
hadn’t applied for the grant because we could have moved faster
without it than with the grant. So the interest to move from volume
has always been driven by the states because, like has been stated, it
11

Linda Qiu, Schumer: Trump and his HHS Pick Tom Price at Odds on Medicare,
POLITIFACT (Jan. 10, 2017, 1:58 PM) http://www.politifact.com/truth-ometer/statements/2017/jan/10/charles-schumer/schumer-trump-and-his-hhs-pick-tomprice-odds-medi/.
12
42 U.S.C. § 1315a.
13
See Bruce Japsen, As Trump’s HHS Secretary, Tom Price Could Slow Shift to ValueBased Care, FORBES (Nov. 29, 2016, 7:02 AM)
https://www.forbes.com/sites/brucejapsen/2016/11/29/as-trumps-hhs-secretary-tomprice-could-slow-shift-to-value-based-care/#5f8ec250636f; see also Shannon Muchmore,
As HHS Secretary, Price Would Likely Focus on State Healthcare Reform, MODERN
HEALTHCARE (Nov. 22, 2016),
http://www.modernhealthcare.com/article/20161122/NEWS/161129971.
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is a building block to a more functioning market. In and of itself, it
isn’t going to make a functioning market, although it is a critical
tool. Once you get to a point of understanding what all is
encompassed in a particular procedure—from start to finish—then
you are better able to help people understand what all they would be
purchasing and how to compare, apples to apples, both quality and
cost. So, I don’t see that movement stopping. Dr. Price’s more recent
comments are encouraging to a lot of folks. It gives comfort that, in
some form or fashion, there will continue to be a focus and funding
to support greater innovation.
To your point, I think we do see a lot of uncertainty, not just
with providers but also the investment community. There are a lot
of folks holding back to wait and see where things are headed. If
anyone is out there right now trying to get providers to sign a new
agreement with them related to some grant they received, I would
probably think they are going to have a hard time convincing the
provider to change processes and change their systems to
accommodate that right now. So I think the broader system is
pausing, or at least has slowed down, for the moment until we see
more details on what is likely to come. And when those details are
available, things will gear back up and we will begin to see changes
accelerate once again.
Professor Farringer: Do you think that is true for accountable
care organizations (ACOs)?
Mr. Gordon: I do think that is true for some ACOs. It depends on
where or how they originated. Some ACOs came directly out of
grant funding from Medicare. Others originated more organically–
driven by local market dynamics. Some ACOs were born out of a
change in the healthcare world more generally. But if, let’s say,
Medicare suddenly does back out, of participating in ACOs, then the
ACOs are going to be hard-pressed to make it work. Could they
continue? Yes. The big question would be what would be
everyone’s purchasing situation? If I as a payer go to Vanderbilt and
I say I am going to do an ACO arrangement this way and another
person says they will do it a different way, and another says they
will do it yet another way, you are setting Vanderbilt, and the
model, up for failure. So, if any one of those large payers back out,
then an ACO is going to struggle to bet a viable option. And I don’t
think we know enough at this point.
Mr. Cowart: I think it is important to understand that in the 50+
years we have had Medicare, it was principally a fee for service
programs; Part A for hospitals and Part B for doctors and
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outpatients. In the early 90s, Part C, Medicare Advantage is created,
and then Medicare Part D under President Bush for pharmacy
benefits. You had essentially two models at both ends of the
spectrum - fee for service and capitation. What is in the middle is a
shared savings program. Medicare’s version of that is called an
Accountable Care Organization. And there is a lot in the private
sector also private payers. So, I think there is going to be a lot of
activity in the shared savings space—that is not limited only to
Medicare ACOs.
Professor Farringer: It will just be how we all coalesce.
Mr. Regier: Well, I mean the clear impetus is to say to the provider
community, (from the payer’s side), “we expect you to be prepared
to accept financial and operating risks for a population of our
enrollees for a period of time, and for all the services they need from
the beginning of life to the end of life.” So, there is flexibility in how
you do that. Like, how you structure that kind of a model. We have
taken the approach today to try to assemble an affiliated network, on
the theory that you cannot afford to own everything. An affiliated
network, to one day be in the position to be able to accept that degree
of risk for a population, is difficult. So that is one way that you can
try to position yourself to be like an ACO at that level.
Mr. Gordon: One last point on that…any of those payment or
quality initiatives that we have talked about in this conversation,
require some degree of alignment. States are out there and they are
trying out new things and so are the private payers, they are out
front. And everyone is concerned what Medicare is going to do. All
the efforts over the last 5 years since the states were investing in this
could all be for nothing if Medicare goes in a completely different
direction. If they go in another direction it can shift the entire
system. So that is something that everyone is going to want to watch.
Not so much “will an ACO develop?” I think the elements and the
principles behind those are fine. I think that the principles will still
be there. I think the question will be “will Medicare come out with
a direction or will they let it be something that everyone else
drives?”
Professor Farringer: Okay! So, one other thing that has been talked
about, I think it was talked about in the debates leading up to the
Presidential election and significantly since the election, is the idea
that we would include in any replacement plan the ability of people
to purchase insurance across state lines. So, maybe talk about that a
little bit to the audience and tell us some of the pros and cons of the
approach and why its proponents say it would ultimately reduce
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healthcare spending. And then any legal concerns that might come
up with that – especially I think on the insurance side from the state’s
perspective. States all have their own insurance laws that are driven
towards protecting their residents, related to making sure that their
residents and insurers of the state are not doing things that are hurtful
to their own residents. So, what are some of the legal implications
for states as we think through this?
Mr. Cowart: Sure. We might need a primer on Repeal and Replace
before we do a primer on insurance. Repeal and Replace is a
campaign term. We are not going to replace the Affordable Care Act
without 60 Republican senators. And you may recall six years ago
when Scott Brown won the election in Massachusetts, there were
only 59 Democrat Senators. Because they attempted to cram through
the Affordable Care Act, there are many technical errors. And they
ultimately had to pass it through using budget reconciliation. For
those law students who are here, the House represents the passion of
the People. They pass things pretty much on party lines. The Senate
is supposed to be the waiting pot for deliberation, so it takes 60 votes
to suspend debate, or cloture. It is not 60 votes to pass. So that’s why
that magic number is 60; otherwise you have filibusters. Now one
of the things that is exempt from cloture is the federal budget. The
nation needs to have an annual budget. So it only requires a majority.
And by the way, since we are watching it on TV every morning, the
Democrats decided that every confirmation, except the United
States Supreme Court, is exempt from cloture. The nominees are all
going to be confirmed unless there is some crime in their
background. On Repeal and Replace, it is largely going to be budgetdriven because of reconciliation—it’s got to be. It’s going to take
away the individual mandate,14 take away the employer mandates,15
and the Cadillac tax,16 and take away the medical device tax,17 all of
which produces the money to fund everything. Without new taxes
you can’t do much because you don’t have any money. So the
reformers have got to say “what can we do that doesn’t require new
taxes?” Because also we want to pass tax reform. All that is kind of
a stage. You have to understand that you have to fill the vacuum
14

26 U.S.C. § 5000A (West 2017); see also78 FED. REG. 78256-01 (Dec. 26, 2013) (to be
codified at 26 C.F.R. at pts. 1 and 602); See e.g., Ctrs. for Medicare and Medicare Servs.,
The Fee for Not Having Health Insurance, HEALTHCARE.GOV,
https://www.healthcare.gov/fees/fee-for-not-being-covered/ (last visited Nov. 1, 2017).
15
26 U.S.C. § 4980H; see also Internal Rev. Serv., Questions and Answers on Employer
Shared Responsibility Provisions Under the Affordable Care Act, U.S. Dep’t of Treasury,
https://www.irs.gov/affordable-care-act/employers/questions-and-answers-on-employershared-responsibility-provisions-under-the-affordable-care-act (last visited Nov. 1, 2017).
16
26 U.S.C. § 4980I.
17
Internal Rev. Serv., Medical Devise Excise Tax, U.S. Dep’t of Treasury,
https://www.irs.gov/newsroom/medical-device-excise-tax-frequently-asked-questions
(last visited Nov. 1, 2017).

12

BELMONT PRACS. GUIDE TO HEALTH L. & POL’Y

VOL. 1

with something. If you want to know the founding of Repeal and
Replace principles, there was a Blair House summit18 with five
leading Democrats and five leading Republicans, go to the CSPAN
in the archives, find the Republican plan of the summit, and those
are the building blocks.19 One of those building blocks is insurance
across state lines. Insurance across state lines is really likely. When
we look at auto insurance, costs are down. It is a lot less expensive
than it used to be because it is a highly competitive model. For auto
insurance, there are all kinds of coverage packages. The Affordable
Care Act20 has a standard national benefit package. We mustn’t
change that. We must also end up with more catastrophic coverage.
The process thus far is whoever can provide the cheapest price gets
the business. People buy on price, not on benefits. Unless they are
really sick, and then, if you are an insurer, you don’t want them to
buy anything. The other thing is, we never federalized any insurance
regulation. Property, casualty, and life insurance, since the early
1900s, has been regulated by the states. The whole concern of the
state insurance commissioners has been to try and regulate this in
some way. It has them scared—I mean really scared. And
particularly in states like Tennessee where the insurance
commissioner doesn’t have a lot of statutory authority.
Professor Farringer: Read between the lines! I was going to ask
you about that. Do you think it is too difficult?
Mr. Gordon: I think it is going to happen. I think it will pass. I think
you will see that. I think where it will fall is less clear. I think all our
crystal balls are out of order. I think it will pass, the question will
be, is it realistic? And also, how will it play out? Each state’s
commissioner of insurance has developed a set of regulatory
guidelines and regulatory frameworks. For them to say that their
own standards are not good standards would be unusual. To have
someone come into your state and not abide by those standards, is
probably going to be problematic. An Insurance commissioner
would likely be a little concerned about that. But I also think about
it from a market perspective because in some cases it is not because
of the regulatory framework that a plan isn't going into a market.
Even if you change the regulatory criteria, they will still have to
18

White House Health Care Summit, Part 1, C-SPAN (Feb. 25, 2010) https://www.cspan.org/video/?292260-1/white-house-health-care-summit-part-1; see also Kristi Keck,
John Helton and David DeSola, Highlights from Obama’s Health Care Summit, CNN
POLITICS (Feb. 25, 2010 9:12 PM)
http://www.cnn.com/2010/POLITICS/02/25/health.care.summit.updates/index.html.
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Noam N. Levey and Kyle Kim, A Side-by-Side Comparison of Obamacare and the
GOP’s replacement plans, L. A. TIMES (July 13, 2017).
20
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make a business decision on how likely they could be successful in
penetrating that market. If it is just not something that they think
they can do successfully, regardless of the regulatory environment,
then they just won't do it. If you think about what is involved when
you take my insurance product and move from Tennessee to
Alabama, then that insurance company has to maintain a presence
there and establish provider networks there to support mer. We will
just have to see how that plays out. There will be a long run-away
before we see it play out and get a better sense of the practical
implications of that.
Mr. Gordon: I like the theory of it, I am just stumbling over the
details of how you are actually going to make this work. Are you
going to have a federally mandated set of minimum benefits that
must be offered as a condition of federal law? And then, how
transparent is that going to be to a consumer? If the approach is that
there would be some set of standard disclosure requirements, and
consumers could at least look at some standard format to say “this
is clearly what is covered, this is what I’m getting,” that kind of
conversation might be helpful to a consumer trying to compare their
options. How you have that for 50 states, which already have an
established framework, is going to require a long time to create and
implement. It will take a long, long time. And I suspect that there
will be many theories on how that will and ought to be done. There
are some folks that are very aggressive and there are other states that
are not as aggressive from a regulatory perspective, and so how does
that all play out?
Professor Farringer: Okay, let’s jump a little bit into…Dick, you
alluded to one of the biggest things that has been mentioned—the
removal of the individual mandate, which is the removal of the
requirement that all purchase insurance, either under an exchange or
through their employer. So, there has not been a lot of talk of the
other two pegs of that equation, which are subsidies and credits
provided to individuals that cannot afford insurance, and then also
the fact that right now insurers cannot deny insurance to those
individuals with preexisting conditions. So, talk to me about the
individual mandate. And if the administration says that we are not
going to enforce it or if that is the only piece that changes, what is
the implication? What do insurers think about that? What do
providers think about that? What are the implications?
Mr. Cowart: At least politically, Congress has to keep the no
preexisting condition provision21 and they have to keep the children,
21
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up to age 26,22 on the parent’s policy provision—those are key. But
again, what Congress does next is dependent on how much money
is available and whether they reconcile tax cuts while removing (the
“repeal” part is removing that tax part) the tax credits. At the end of
the day you have “x” amount of dollars. It is not nearly the same
amount of money that Congress had under the Affordable Care Act.
I think that these will be tax credits. There is some discussion about
making it catastrophic coverage credit, so making it kind of a
chronic disease super fund that is administrated at the state levels.
To say that these are available in a catastrophe, the government’s
role in funding this and the citizen’s role in funding primary care.
So I believe that there will not be an individual mandate. There is
probably going to be an employer mandate. That is just an anathema
to this administration.
Mr. Regier: I am going to say this, part of the deal from the hospital
industry’s perspective, part of the deal was “we are going to get an
coverage expansion and so we hospitals are going to suck it up and
take reductions in Medicare payments and in disproportionate share
funding.” So that deal, now appears to be going away. I am very
concerned just as a public health matter at the number of people who
will no longer have insurance. I have heard too many people still
saying “repeal and restore.” A number of folks are saying “we are
getting rid of this horrible bill and we are going to restore choice”—
well, choice was no insurance for 47 million people in this country.
That was not a choice and that is not acceptable. So that, I think, is
going to be a very big priority for the provider side. And I am
encouraged because the President has said that it is going to be huge,
it is going to be great, and it is going to be wonderful. And, at
Vanderbilt, I would say that we are ready to sit down and talk with
anybody at any time and at any place to collaborate on a plan to
increase access to coverage for people in Tennessee and the
surrounding states.
Professor Farringer: What about insurers?
Mr. Gordon: Providers and insurers actually are in agreement on
the idea of broadly based coverage, for a variety of reasons. Really,
on the insurance side, the whole idea behind the mandate was to
balance out the risk pools. States that have expanded to 138% of the
poverty level, took on some of the risk for those that were 100-138%
of poverty that would have otherwise been incurred in the individual
market in those states and that may have moderated the risk in those
22
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markets, but even so, there were still problems. Risk adjustments,
risk corridors and reinsurance would have helped stabilize the
market as well but these common actuarial tools ended up getting
caught in the political world and were not fully leveraged. If you use
these actuarial levers that are common to stabilize a volatile market,
you help to balance out some of the issues. We would not have seen
the degree of issues that seem to have played out across the country
if those tools could have been more fully used. I say all that but the
individual mandate was also supposed to be a way to try to balance
out all that, but it didn't work. There is a lot of interconnectedness.
Does that mean you cannot do things? No. It just means you have to
understand how all these things fit together. I, personally, was not
convinced that the way that the individual mandate was structured,
that it, had enough of an effect that people were looking for and
hoped for. So, that one component, and I haven’t seen information
out there that says “those that got insured, that the mandate was the
biggest driver or if it was the subsidies?” So the question is what
works most effectively? A lot would argue, it goes back to Dick’s
point, people are very price sensitive. When you look at the
penalties, I mean, I had people reach out to me saying “I did the
math, I want a non-ACA plan, it is significantly less costly than an
ACA compliant plan.” 23 But I would say, in looking at the entire
system, you have to recognize that price matters.
Mr. Cowart: Michael mentioned one phrase I want to—one of the
big wild cards—“Repeal and Restore.” The “Restore” piece depends
on provider unity. If you are in the South, you needed to expand
Medicaid to get whole. There are many moving parts. If we are
going to end up with an auto insurance model, providers may close
ranks and say “Restore my Medicare cuts.” Restore my Medicare
payments and I’ll deal with that. And it would not be a bad judgment
call for a provider. If you restore these healthcare cuts and you
eliminate the taxes, there is no money to fund anything. That is why
you end up with these local options—because there is no money
except for a few tax credits.
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